GSDX

ASSAYS

Our extensive assay menu meets the needs of any laboratory.

Learn More >>

INSTRUMENTS

An innovative suite of instruments will increase quality and consistency for your lab.

Learn More >>

SERVICES

We know diagnostics and have you covered from technical support to product development.

Learn More >>

DISTRIBUTORS

GSD offers cost-effective laboratory automation solutions for sale around the globe.

Learn More >>

CLINICAL LABORATORIES

GSD provides a total solution that improves laboratory efficiency while reducing costs.

Learn More >>

MANUFACTURERS

Sell your diagnostic products to the large U.S. clinical laboratory market.

Learn More >>

COVID-19

GSD is proud to announce multiple solutions to help diagnose COVID-19.

PCR ID>>

NEWS

April 22, 2021

Improved Lyme Screening Assay Now FDA Cleared for Laboratory Use

B. burgdorferi VlsE-OspC IgG/IgM Assay helps with early Lyme Disease detection

April 1, 2021

Gold Standard Diagnostics Announces FDA Clearance of the B. burgdorferi IgG/IgM VlsE-OspC EIA Test

Gold Standard Diagnostics (GSD), a Eurofins Technologies company, today announced FDA clearance of a new B. burgdorferi IgG/IgM VlsE-OspC EIA test.

October 6, 2020

Gold Standard Diagnostics Receives FDA 510K for Lyme IgG and IgM EIA Kits

The Gold Standard Diagnostics Group (GSD) today announced the immediate availability of their two new Lyme IgG and Lyme IgM EIA kits for detection of antibodies against Lyme disease causing bacteria.

Look inside Oculus

ASSAYS

INSTRUMENTS

SERVICES

DISTRIBUTORS

CLINICAL LABORATORIES

MANUFACTURERS

COVID-19

Improved Lyme Screening Assay Now FDA Cleared for Laboratory Use

Gold Standard Diagnostics Announces FDA Clearance of the B. burgdorferi IgG/IgM VlsE-OspC EIA Test

Gold Standard Diagnostics Receives FDA 510K for Lyme IgG and IgM EIA Kits

NYSCLA

SCASM

SERVICES

LYME

INSTRUMENTS

COVID-19

ASSAYS

Connect

Categories